We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Pediatric HAIs Are the Most Common Type

By LabMedica International staff writers
Posted on 26 Jan 2017
The prevalence and type of health care-associated infections (HAIs) in children in Europe and risk factors for infection in this population has been described in a multinational study.

Point-prevalence surveys offer an alternative method to incidence surveillance to estimate the hospital-wide burden of health-care-associated infections within a reasonable budget. More...
Thus, they can be used a wider range of settings including institutes with limited resources and allow broader comparison of rates across a wider range of socio-cultural contexts.

A large group of scientists associated with the European Centre for Disease Prevention and Control (ECDC) analyzed data from the ECDC point prevalence survey of HAIs and antimicrobial use in European acute care hospitals 2011-2012, and included 770 infections reported in 726 children and adolescents. The findings show that the prevalence of infections was highest in pediatric intensive care units where one in six children were infected (15.5%) and neonatal intensive care units, where one in ten babies (10.7%) where infected. Most HAIs (77%) were identified in infants younger than 12 months.

Bloodstream infections were the most common type of infection (45%), followed by lower respiratory tract infections (22%). Although the vast majority of bloodstream infections in the study were reported in infants younger than 12 months, the proportion remained high in other age groups as well. This type of infections in neonates and children are associated with a high mortality and long-term adverse neurological outcomes. The team reported 392 microorganisms in 342 (44%) of the 770 health-care-associated infections; 343 (88%) were bacteria, 28 (7%) fungi, and 21 (5%) viruses. Enterobacteriaceae were the most commonly isolated microorganisms (113 [15%]), followed by coagulase-negative staphylococci and Staphylococcus aureus. Of the few reported viruses, rotaviruses were the most frequently identified (13 of 21 isolates).

The authors stated that a pan-European programme is urgently required to prevent and reduce the unacceptably high rates of HAIs in children in Europe, with a focus in neonatal and pediatric intensive care units and addressing the issues related to healthcare-associated bloodstream infections. The study was published on January 13, 2017, in the journal The Lancet Infectious Diseases.


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
New
C-Reactive Protein Assay
OneStep C-Reactive Protein (CRP) RapiCard InstaTest
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.